#SOLARA | 👔 Solara Active Pharma Sciences announced its board approved unaudited financial results for Q3'25, with revenues at INR 3,018 Mn, gross margins at 55%, and EBITDA margins at 19.6%. 
Details:⚡ AI powered update byCheck-outto receive WhatsApp updates faster than twitter/X.
#SOLARA